
Joseph J. Kukella
Examiner (ID: 18482, Phone: (571)272-4679 , Office: P/2913 )
| Most Active Art Unit | 2913 |
| Art Unit(s) | 2961, 2913 |
| Total Applications | 1553 |
| Issued Applications | 1431 |
| Pending Applications | 3 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18853878
[patent_doc_number] => 11851439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Compositions and methods of use for opioid hexadienoates and optionally substituted hexadienoates
[patent_app_type] => utility
[patent_app_number] => 17/305215
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 8597
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305215 | Compositions and methods of use for opioid hexadienoates and optionally substituted hexadienoates | Jun 30, 2021 | Issued |
Array
(
[id] => 18628124
[patent_doc_number] => 20230286953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS AND INTERMEDIATES FOR PREPARING JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/013380
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013380
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013380 | METHODS AND INTERMEDIATES FOR PREPARING JAK INHIBITORS | Jun 28, 2021 | Pending |
Array
(
[id] => 19265255
[patent_doc_number] => 20240208954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/013696
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013696
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Jun 28, 2021 | Pending |
Array
(
[id] => 17334525
[patent_doc_number] => 20220000856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => 1',3'-Disubstituted-4-Phenyl-3,4,5,6-Tetrahydro-2H,1'H-[1,4']Bipyridinyl-2'-Ones
[patent_app_type] => utility
[patent_app_number] => 17/354194
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17354194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/354194 | 1',3'-Disubstituted-4-Phenyl-3,4,5,6-Tetrahydro-2H,1'H-[1,4']Bipyridinyl-2'-Ones | Jun 21, 2021 | Abandoned |
Array
(
[id] => 18341235
[patent_doc_number] => 11638704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Bicyclic compounds and their use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/354010
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 23645
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17354010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/354010 | Bicyclic compounds and their use in the treatment of cancer | Jun 21, 2021 | Issued |
Array
(
[id] => 17141627
[patent_doc_number] => 20210309639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => SOLID STATE FORMS OF IVOSIDENIB
[patent_app_type] => utility
[patent_app_number] => 17/351605
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/351605 | Solid state forms of ivosidenib | Jun 17, 2021 | Issued |
Array
(
[id] => 18170322
[patent_doc_number] => 20230036933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => HETEROCYCLIC INHIBITORS OF ENPP1
[patent_app_type] => utility
[patent_app_number] => 17/348607
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348607 | Heterocyclic inhibitors of ENPP1 | Jun 14, 2021 | Issued |
Array
(
[id] => 17334528
[patent_doc_number] => 20220000859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => LFA-1 INHIBITOR FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/342631
[patent_app_country] => US
[patent_app_date] => 2021-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342631
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342631 | LFA-1 INHIBITOR FORMULATIONS | Jun 8, 2021 | Abandoned |
Array
(
[id] => 18435886
[patent_doc_number] => 20230183180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PROCESS OF MAKING ROXADUSTAT
[patent_app_type] => utility
[patent_app_number] => 17/924850
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/924850 | PROCESS OF MAKING ROXADUSTAT | Jun 3, 2021 | Abandoned |
Array
(
[id] => 18980124
[patent_doc_number] => 11905284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => 5,7-dihydro-pyrrolo-pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 17/335666
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44589
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335666 | 5,7-dihydro-pyrrolo-pyridine derivatives | May 31, 2021 | Issued |
Array
(
[id] => 17185177
[patent_doc_number] => 20210332062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/334098
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334098 | HETERO-SUBSTITUTED CYCLIC LACTONE ANALOGUES AND USES THEREOF | May 27, 2021 | Abandoned |
Array
(
[id] => 17081933
[patent_doc_number] => 20210276939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION
[patent_app_type] => utility
[patent_app_number] => 17/326738
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326738 | BUTYL-BRIDGED DIPHOSPHINE LIGANDS FOR ALKOXYCARBONYLATION | May 20, 2021 | Abandoned |
Array
(
[id] => 17385520
[patent_doc_number] => 20220033372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS AND COMPOSITIONS RELATING TO GENOTOXIN COLIBACTIN
[patent_app_type] => utility
[patent_app_number] => 17/325747
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325747 | METHODS AND COMPOSITIONS RELATING TO GENOTOXIN COLIBACTIN | May 19, 2021 | Abandoned |
Array
(
[id] => 18537428
[patent_doc_number] => 20230242520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MALONITRILE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/999196
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999196 | MALONITRILE DERIVATIVES | May 17, 2021 | Abandoned |
Array
(
[id] => 18435887
[patent_doc_number] => 20230183181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => PROCESS OF PREPARING BUTYL-(5S)-5-({2-[4-(BUTOXYCARBONYL)PHENYL]ETHYL}[2-(2-{[3-CHLORO-4'-(TRIFLUOROMETHYL)[BIPHENYL]-4-YL]METHOXY}PHENYL)ETHYL]AMINO)-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLATE
[patent_app_type] => utility
[patent_app_number] => 17/999179
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999179 | PROCESS OF PREPARING BUTYL-(5S)-5-({2-[4-(BUTOXYCARBONYL)PHENYL]ETHYL}[2-(2-{[3-CHLORO-4'-(TRIFLUOROMETHYL)[BIPHENYL]-4-YL]METHOXY}PHENYL)ETHYL]AMINO)-5,6,7,8-TETRAHYDROQUINOLINE-2-CARBOXYLATE | May 13, 2021 | Pending |
Array
(
[id] => 19012998
[patent_doc_number] => 11919913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => 4-phenylpiperidines, their preparation and use
[patent_app_type] => utility
[patent_app_number] => 17/320158
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 31724
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320158 | 4-phenylpiperidines, their preparation and use | May 12, 2021 | Issued |
Array
(
[id] => 18484859
[patent_doc_number] => 20230212168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => ENDOCYCLIC PYRIMIDINONE COMPOUNDS, AND PREPARATION METHODS, COMPOSITIONS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/998569
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998569 | ENDOCYCLIC PYRIMIDINONE COMPOUNDS, AND PREPARATION METHODS, COMPOSITIONS AND USE THEREOF | May 11, 2021 | Pending |
Array
(
[id] => 18435940
[patent_doc_number] => 20230183234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => IAP ANTAGONIST COMPOUNDS AND INTERMEDIATES AND METHODS FOR SYNTHESIZING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/923188
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923188
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923188 | IAP ANTAGONIST COMPOUNDS AND INTERMEDIATES AND METHODS FOR SYNTHESIZING THE SAME | May 2, 2021 | Pending |
Array
(
[id] => 18995833
[patent_doc_number] => 11912659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => EBNA1 inhibitors and methods using same
[patent_app_type] => utility
[patent_app_number] => 17/232511
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43288
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232511 | EBNA1 inhibitors and methods using same | Apr 15, 2021 | Issued |
Array
(
[id] => 18511277
[patent_doc_number] => 20230227411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Benzimidazole Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/996323
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996323 | Benzimidazole Derivatives | Apr 13, 2021 | Pending |